News from NINDS


Epilepsy drug discovered in fish model shows promise in small pediatric clinical trial

“Bench-to-bedside” describes research that has progressed from basic science in animal models that has led to therapies used in patients. Now, a study in the journal Brain describes what could be considered a direct “aquarium-to-bedside” approach, taking a drug discovered in a genetic zebrafish model of epilepsy and testing it, with promising results, in a small number of children with the disease.

Read Full Article

Third meeting of the BRAIN MCWG Neuroethics Division

February 14, 2017

The third meeting of the MCWG Neuroethics Division will occur on Tuesday, February 14th, 2017 at 9 a.m. at the NIH Porter Neuroscience Research Center (35 Convent Dr., Bethesda, MD 20892).

Read Full Article

Doctor Walter Koroshetz

Director's Message

In July 2015, NINDS issued the first funding opportunity announcement for the R35 Research Program Award (RPA). The RPA is designed to encourage ambitious, creative science by providing stable funding to outstanding investigators’ research programs, offering them the freedom to pursue longer-term, innovative research projects. I am thrilled to announce that NINDS has named the first recipients of this new award.

Read complete Director's Message  

 

Resources for